Markets:

Overview

News

Currencies

International

Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

22.26 +0.14 (+0.63%)

Streaming Delayed Price Updated: 10:36 AM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GH Research PLC - Ordinary Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD ↗

December 24, 2021

All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD?

Via Talk Markets

The Year In Review For Psychedelic Drug Stocks: 2021 ↗

December 21, 2021

2021 was two different

Via Talk Markets

Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline ↗

December 12, 2021

The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...

Via Talk Markets

Topics Cannabis

GH Research Announces Positive Trial Results For Treatment-Resistant Depression ↗

December 06, 2021

Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ: GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy...

Via Benzinga

60 Biggest Movers From Yesterday ↗

December 07, 2021

Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore...

Via Benzinga

GH Research Posts Data From Treatment-Resistant Depression Trial ↗

December 06, 2021

GH Research PLC (NASDAQ: GHRS) has reported the outcome of the Phase 2 part of a Phase 1/2 trial of GH001, an inhalable 5-MeO-DMT product candidate for treatment-...

Via Benzinga

Psychedelic Drug Stocks Continued To Decline Last Week ↗

November 21, 2021

The 12 constituents in our Pure-Play Psychedelic Compounds-Based Drug Stocks Index declined -5.7% last week; it's now -16.1% so far in November.

Via Talk Markets

61 Biggest Movers From Yesterday ↗

November 18, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...

Via Benzinga

Topics Initial Public Offering

42 Stocks Moving In Wednesday's Mid-Day Session ↗

November 17, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...

Via Benzinga

Topics Initial Public Offering

Mike Tyson: How A Drug Derived From Toad Venom Made Him Comfortable With Dying ↗

November 16, 2021

Besides being one of the most intimidating human beings ever to step into the boxing ring, former heavyweight champion Mike Tyson ...

Via Benzinga

Compass Pathways 2.0: A New Rally In Psychedelic Stocks? ↗

November 04, 2021

Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat?

Via Talk Markets

Topics Initial Public Offering

66 Biggest Movers From Friday ↗

November 01, 2021

Gainers Bakkt Holdings, Inc. (NASDAQ: BKKT) shares surged 66.1% to close at $42.52 on Friday on continued volatility after the company recently announced partnerships with...

Via Benzinga

Mid-Afternoon Market Update: Gold Down 1%; A10 Networks Shares Gain Following Q3 Results ↗

October 29, 2021

Toward the end of trading Friday, the Dow traded down 0.03% to 35,721.05 while the NASDAQ fell 0.07% to 15,437.03. The S&P also fell, dropping 0.08% to 4,592.96. The U.S. has...

Via Benzinga

Topics Stocks

Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148% ↗

October 24, 2021

The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD.

Via Talk Markets

Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 ↗

October 15, 2021

Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month.

Via Talk Markets

Psychedelic Drug Industry Report Card For 2021 ↗

September 01, 2021

In assessing the psychedelic drug industry, a primary focus for investors is drug development.

Via Talk Markets

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation ↗

October 18, 2021

The Week In Psychedelics

Via Benzinga

Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance" ↗

July 23, 2021

Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday,

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021 ↗

July 20, 2021

Upgrades For Bank of Marin Bancorp (NASDAQ:

Via Benzinga

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are ↗

October 13, 2021

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...

Via Benzinga

Opening Day: Wahlberg-backed Gym Owner F45 Opens Higher In Public Debut ↗

July 18, 2021

Mark Wahlberg-backed F45 Training rose as much as 11% in its trading debut but fell near the offer price after its $325M IPO on Thursday. The listing was delayed by the COVID-19 pandemic and then...

Via Talk Markets

Topics Initial Public Offering

63 Biggest Movers From Friday ↗

August 02, 2021

Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...

Via Benzinga

Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies ↗

July 07, 2021

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps...

Via Benzinga

Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies ↗

July 02, 2021

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o...

Via Benzinga

55 Biggest Movers From Friday ↗

June 28, 2021

Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ:...

Via Benzinga

Software Startup Sprinklr Falls In Market Debut, More IPO News ↗

June 27, 2021

Shares of Sprinklr fell almost 9% in their market debut on Wednesday, valuing the startup at $3.7B. The software company counts Microsoft and Verizon as customers. Didi and Krispy Kreme are among...

Via Talk Markets

Topics Initial Public Offering

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.